PATRICIA GANJA: Open Payments
NPI 1457605289 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,218 in 52 payments from 22 companies in 2025. Trend: 2023 $1,402 · 2024 $808 · 2025 $1,218
Food & beverage: $1,218
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 6 | $231 |
| Novo Nordisk Inc | 7 | $163 |
| ABBVIE INC. | 5 | $109 |
| Amgen Inc. | 5 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $86 |
| KYOWA KIRIN, INC. | 3 | $78 |
| Neurocrine BioSciences, Inc. | 2 | $56 |
| Soleno Therapeutics, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $44 |
| Madrigal Pharmaceuticals | 1 | $42 |
Products named: Dexcom G6 Transmitter, Ozempic, JARDIANCE, CRYSVITA, CRENESSITY, TEPEZZA, VYKAT XR, REZDIFFRA.
Industry payments across NV — which companies pay providers there.
